Literature DB >> 20403436

The tri-nucleotide spacer sequence between estrogen response element half-sites is conserved and modulates ERalpha-mediated transcriptional responses.

Feng-Jue Shu1, Neil Sidell, Danzhou Yang, Caleb B Kallen.   

Abstract

The estrogen response element (ERE) consensus sequence is AGGTCAnnnTGACCT, where nnn is known as the tri-nucleotide spacer sequence. Studying 1017 high-confidence ERalpha-bound loci, we found that genomic EREs are enriched for spacers composed of C(A/T)G, suggesting that the spacer may influence receptor binding and transcriptional responses. We designed consensus EREs containing variable spacer sequences and compared ERalpha binding in gel shift assays and enhancer function in reporter assays. We found that ERalpha-ERE binding affinity is modulated by the tri-nucleotide spacer sequence and is favored by spacer sequences of CTG>GCC>TTT. Similarly, luciferase reporter assays indicated that the estrogen-stimulated transcriptional response is modulated by the spacer and parallels the gel shift data: CTG>GCC>TTT. Reporter assays demonstrated that the spacer sequence also modulates the sensitivity of EREs to repression engendered by the receptor antagonist hydroxytamoxifen. These experiments indicate that the sequence of the tri-nucleotide spacer is non-random at receptor-bound genomic loci, influences ERalpha-DNA-binding affinity, and modulates transactivation potential of the receptor-ligand-DNA complex. This work has implications for understanding which genomic EREs are targeted by ERalpha, should improve computational prediction of functional EREs within genomic sequences, and describes novel sequence determinants of the estrogen response. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20403436      PMCID: PMC2891080          DOI: 10.1016/j.jsbmb.2010.04.009

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  66 in total

1.  Genome-wide identification of high-affinity estrogen response elements in human and mouse.

Authors:  Véronique Bourdeau; Julie Deschênes; Raphaël Métivier; Yoshihiko Nagai; Denis Nguyen; Nancy Bretschneider; Frank Gannon; John H White; Sylvie Mader
Journal:  Mol Endocrinol       Date:  2004-03-04

2.  Binding of the estrogen receptor DNA-binding domain to the estrogen response element induces DNA bending.

Authors:  A M Nardulli; D J Shapiro
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

3.  Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.

Authors:  K Paech; P Webb; G G Kuiper; S Nilsson; J Gustafsson; P J Kushner; T S Scanlan
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

4.  Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1998-05-16       Impact factor: 79.321

5.  Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters.

Authors:  A M Nardulli; L E Romine; C Carpo; G L Greene; B Rainish
Journal:  Mol Endocrinol       Date:  1996-06

6.  The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements.

Authors:  J W Schwabe; L Chapman; J T Finch; D Rhodes
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

7.  The cocrystal structures of two zinc-stabilized DNA-binding domains illustrate different ways of achieving sequence-specific DNA recognition.

Authors:  J W Schwabe; L Fairall; L Chapman; J T Finch; R N Dutnall; D Rhodes
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1993

8.  Estrogen response elements function as allosteric modulators of estrogen receptor conformation.

Authors:  J R Wood; G L Greene; A M Nardulli
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

9.  Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells.

Authors:  V Krishnan; X Wang; S Safe
Journal:  J Biol Chem       Date:  1994-06-03       Impact factor: 5.157

Review 10.  Genomic targets of nuclear estrogen receptors.

Authors:  Raegan O'Lone; Martin C Frith; Elinor K Karlsson; Ulla Hansen
Journal:  Mol Endocrinol       Date:  2004-03-18
View more
  9 in total

1.  Bisphenol-A induces expression of HOXC6, an estrogen-regulated homeobox-containing gene associated with breast cancer.

Authors:  Imran Hussain; Arunoday Bhan; Khairul I Ansari; Paromita Deb; Samara A M Bobzean; Linda I Perrotti; Subhrangsu S Mandal
Journal:  Biochim Biophys Acta       Date:  2015-02-25

2.  From Influenza Virus Infections to Lupus: Synchronous Estrogen Receptor α and RNA Polymerase II Binding Within the Immunoglobulin Heavy Chain Locus.

Authors:  Bart G Jones; Robert E Sealy; Rhiannon R Penkert; Sherri L Surman; Barbara K Birshtein; Beisi Xu; Geoffrey Neale; Robert W Maul; Patricia J Gearhart; Julia L Hurwitz
Journal:  Viral Immunol       Date:  2020-02-27       Impact factor: 2.257

Review 3.  DNA Recognition by a Novel Bis-Intercalator, Potent Anticancer Drug XR5944.

Authors:  Clement Lin; Danzhou Yang
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

4.  Intercalation of XR5944 with the estrogen response element is modulated by the tri-nucleotide spacer sequence between half-sites.

Authors:  Neil Sidell; Raveendra I Mathad; Feng-jue Shu; Zhenjiang Zhang; Caleb B Kallen; Danzhou Yang
Journal:  J Steroid Biochem Mol Biol       Date:  2011-02-17       Impact factor: 4.292

5.  In-silico identification and functional validation of allele-dependent AR enhancers.

Authors:  Sonia Garritano; Alessandro Romanel; Yari Ciribilli; Alessandra Bisio; Antoneta Gavoci; Alberto Inga; Francesca Demichelis
Journal:  Oncotarget       Date:  2015-03-10

6.  Solution structure of a 2:1 complex of anticancer drug XR5944 with TFF1 estrogen response element: insights into DNA recognition by a bis-intercalator.

Authors:  Clement Lin; Raveendra I Mathad; Zhenjiang Zhang; Neil Sidell; Danzhou Yang
Journal:  Nucleic Acids Res       Date:  2014-04-07       Impact factor: 16.971

7.  ANRIL Promoter DNA Methylation: A Perinatal Marker for Later Adiposity.

Authors:  Karen Lillycrop; Robert Murray; Clara Cheong; Ai Ling Teh; Rebecca Clarke-Harris; Sheila Barton; Paula Costello; Emma Garratt; Eloise Cook; Philip Titcombe; Bhuvaneshwari Shunmuganathan; Samantha J Liew; Yong-Cai Chua; Xinyi Lin; Yonghui Wu; Graham C Burdge; Cyrus Cooper; Hazel M Inskip; Neerja Karnani; James C Hopkins; Caroline E Childs; Carolina Paras Chavez; Philip C Calder; Fabian Yap; Yung Seng Lee; Yap Seng Chong; Philip E Melton; Lawrie Beilin; Rae-Chi Huang; Peter D Gluckman; Nick Harvey; Mark A Hanson; Joanna D Holbrook; Keith M Godfrey
Journal:  EBioMedicine       Date:  2017-04-26       Impact factor: 8.143

8.  Prognostic features of signal transducer and activator of transcription 3 in an ER(+) breast cancer model system.

Authors:  Li-Yu D Liu; Li-Yun Chang; Wen-Hung Kuo; Hsiao-Lin Hwa; Yi-Shing Lin; Meei-Huey Jeng; Don A Roth; King-Jen Chang; Fon-Jou Hsieh
Journal:  Cancer Inform       Date:  2014-01-21

Review 9.  Novel DNA Bis-Intercalator XR5944 as a Potent Anticancer Drug-Design and Mechanism of Action.

Authors:  Adam J Buric; Jonathan Dickerhoff; Danzhou Yang
Journal:  Molecules       Date:  2021-07-07       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.